You are here: Industry Insights > Italy

News List

Catalent Plans $100M Expansion of Biologics Mfg. Capabilities in Italy contractpharma
July 22, 2021
Initial phase includes installation of two 2,000-liter single-use bioreactors and associated investments to support early-and late-phase clinical development.
Ethypharm Establishes Direct Presence in Italy americanpharmaceuticalreview
April 27, 2021
Ethypharm has announced that it now has a fully established affiliate to operate directly in Italy, the third largest pharmaceutical market in Europe.
AstraZeneca Releases Statement on COVID-19 Vaccine Supply at Anagni Plant in Italy americanpharmaceuticalreview
April 02, 2021
The following is a statement from AstraZeneca regarding the company’s vaccine supply at their Anagni Plant in Italy.
Italy blocks export of 250,700 AstraZeneca/Oxford Covid-19 vaccines to Australia pharmaceutical-technology
March 08, 2021
The Italian Government has refused to authorise the export of 250,700 doses of AstraZeneca/University of Oxford’s Covid-19 vaccine to Australia.
Italy gives approval to trial osteoporosis drug for Covid-19 treatment pharmaceutical-technology
October 29, 2020
The Italian Medicines Agency (AIFA) has granted approval to conduct human clinical trials on raloxifene, a generic osteoporosis drug to treat paucisymptomatic Covid-19 patients.
Advanced Clinical Opens New Office in Italy contractpharma
August 14, 2019
Company now able to serve clients in all major markets throughout Western Europe.
Italy free to reimburse off-label Avastin, rules EU court pharmaphorum
November 28, 2018
Novartis and Roche’s long-running battle to try to prevent off-label prescribing of Roche’s Avastin in place of their approved Lucentis product for the eye disease age-related macular degeneration (AMD) has been dealt a blow by the European Court of Justi